BioSpace News Archive

Advancements in technology, surge in prevalence of chronic diseases, and rise in aging population drive the global personal mobility devices market growth.

Increase in incidences of respiratory diseases, technological advancements in spirometers, and growth in geriatric population drive the global spirometer market.

AB Science SA (Euronext - FR0010557264 - AB) today announced the publication of a pathogenic mechanism triggered by mast cells in the amyotrophic lateral sclerosis (ALS) spinal cord that can be targeted by masitinib.

Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and Drug Administration (FDA) has granted a public hearing to discuss Makena, the only FDA-approved treatment, along with its equivalent generics, to reduce preterm birth in indicated patients.

PIH Health Good Samaritan Hospital has a new treatment option available for patients with severely calcified coronary artery disease.

Rockwell Medical, Inc. announced that a majority of the independent directors serving on the Company’s Board of Directors approved the grant of an option to purchase 350,000 shares of the Company’s common stock to Megan C. Timmins, the Company’s Senior Vice President, General Counsel and Secretary.

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today highlighted positive interim clinical data from the Company’s FT516 and FT596 programs for patients with relapsed / refractory B-cell lymphoma.

Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company, announced today that a successful preclinical study has shown its drug candidate LP-184 is able to inhibit tumor growth and improve survival in animal models of glioblastoma (GBM).

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Biotherapeutics, an emerging Boston-based biotechnology company.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today recruitment of Dr. Boris Reznik to the Company’s Advisory Board.